TNFRSF10B and neoplasm: However, CAR-T cells equipped with chimeric co-stimulatory receptors targeting tumor-associated MUC1 (MUC1) can target DR5 expressed on MDSCs, enhancing antitumor potential and promoting TME remodeling and T cell proliferation at the tumor site [99].